Nygard Biotec
Nygard Biotec

The Movie

Peter Nygards 4 Step Strategy:

Step 1: Obtaining the right technology

University of Oregon Scientist, Dr. Shoukhrat Mitalipov explains, “It’s been 15 years since we invented the embryonic stem cell, and no one has been able to figure out how to use it.”   The procedure inserts adult human DNA into an unfertilised human egg, so that the growing stem cells can be used to treat serious disease and ageing.

 

“The way in which these stem cell lines were derived is from embryos that were created in the process of In Vitro Fertlisation (IVF), and, in fact, there are hundreds of thousands of these embryos that are simply being discarded,” said Dr. Francis Collins, Director of the US National Institute of health.

Step 2: Finding the perfect setting

After lengthy international travels, Mr. Nygard settled in the Bahamas for good reason many years ago.  Recognised by its popularity among A-class celebrities and the rich and famous, the Bahamas is a celebrated holiday destination with beautiful weather, a welcoming economy and an ever-friendly culture.  He believes that his new home would be perfect for both his business and the Bahamian people.

Step 3: Educating the law-makers

Mr Nygard needed the Bahamian government to willingly adopt supportive legislation for his stem cell studies.  This was a critical step in the progression of his extensive plans for research. He says that Bahama’s current Prime Minister Perry Christie "showed tremendous courage and political savviness to guide this through the legislature”.

 

PM Christie states in the video above that:“Two years ago Peter Nygård called me to say that if your country is prepared to pass legislation, I will find a way to bring scientists who I have retained. I am prepared to have them come into the Bahamas.”

 

The stem cell bill was passed in January of 2014 and was the first time the Bahamas’ ‘Medical Act’ had been revised in over 12 years. 

Step 4: Planing and construction of the scientific facilities

The construction of a multi-million dollar facility which develops both genomic sequencing and embryonic stem-cell technology would be the first of its kind anywhere in the world. 

 

While importing the most advanced stem cell technologies available, the aim is to also expand research into commercial genome sequencing (GS). This is described as the mapping of an organism’s entire DNA sequence, potentially used to predict one’s risk of developing a range of genetically inherited pathologies. 

Stem Cell News: Science Daily

Computer simulations visualize how DNA converts cells into stem cells (Fri, 14 Feb 2020)
>> Read more

Scientists discover how rogue communications between cells lead to leukemia (Thu, 06 Feb 2020)
>> Read more

Abnormal bone formation after trauma explained and reversed in mice (Thu, 06 Feb 2020)
>> Read more

New hydrogels wither while stem cells flourish for tissue repair (Tue, 04 Feb 2020)
>> Read more

Scientists boost gene-editing tools to new heights in human stem cells (Thu, 30 Jan 2020)
>> Read more

Molecular motors direct the fate of stem cells (Wed, 29 Jan 2020)
>> Read more

New injection technique may boost spinal cord injury repair efforts (Wed, 29 Jan 2020)
>> Read more

After a bone injury, shape-shifting cells rush to the rescue (Wed, 29 Jan 2020)
>> Read more

Six patients with rare blood disease are doing well after gene therapy clinical trial (Wed, 29 Jan 2020)
>> Read more

First treatment for pain using human stem cells a success (Thu, 23 Jan 2020)
>> Read more

Solving a biological puzzle: How stress causes gray hair (Wed, 22 Jan 2020)
>> Read more

Cancer study may accidentally help researchers create usable blood stem cells (Thu, 16 Jan 2020)
>> Read more

Mutations in donors' stem cells may cause problems for cancer patients (Wed, 15 Jan 2020)
>> Read more

Artificial muscle sheets transform stem cells into bone (Mon, 13 Jan 2020)
>> Read more

First genomic study of puberty yields insights into development and cancer (Fri, 10 Jan 2020)
>> Read more

Print Print | Sitemap
© Nygard Biotech